202 JOURNAL OF CHEMICAL RESEARCH 2010
Anal. Calcd for C22H18N4O (354.407): C, 74.56; H, 5.12; N, 15.81.
Found C, 74.40; H, 5.10; N, 15.70.
Anal. Calcd for C H18N O (354.407): C, 74.56; H, 5.12; N, 15.81.
Found C, 74.44; H2,25.08;4N, 15.68.
4p-(4q-Methoxyphenyl)-5p-phenyl-2p,4p-dihydrospiro[indole-3,3p-
[1,2,4]triazol]-2(1H)-one (4c): Colourless crystals (0.3 g, 80%),
m.p. (methanol) 190 °C. IR: nmax = 3338 (NH), 3087–3010 (ArCH),
Professor Ashraf A. Aly thanks the DAAD foundation for the
scholarship that enabled him to carry out NMR spectra analy-
sis in the Institute of Organic Chemistry, TU-Braunschweig
University, Germany.
1
2987–2860 (aliph.-CH), 1680 (C=O), 1610 (C=N), 1586 (C=C). H
NMR: dH = 8.30 (br, s, 1 H, NH, exchangeable with D2O), 8.10 (d,
2 H, J = 7.8), 7.80 (d, 2 H, J = 7.8), 7.70–7.12 (m, 7 H, ArH), 6.90 (m,
2 H, ArH), 6.40 (br, s, 1 H, NH, exchangeable with D2O), 3.90 (s, 3 H,
OCH3). 13C NMR: dC = 169.2 (C=O), 158.0 (C=N), 156.0, 134.4,
132.0, 131.2, 131.0 ArC), 129.2, 128.8 (ArCH), 128.2 (ArCH-p),
127.4 (Ar2CH-o), 127.0, 126.8 (Ar2CH-m), 122.0 (Ar2CH-o), 126.5,
119.0 (ArCH), 90.0 (spiro-C), 51.0 (CH3–Ar). MS (70 eV, EI):
m/z = 370 (56), 342 (22), 327 (22), 249 (30), 210 (77), 160 (24), 113
(28), 110 (100), 91 (22), 77 (20). Anal. Calcd for C22H18N4O2
(370.407): C, 71.34; H, 4.90; N, 15.13. Found: C, 71.30; H, 4.80; N,
15.08.
Received 25 January 2010; accepted 11 March 2010
Paper100979 doi: 10.3184/030823410X12698845637794
Published online: 28 April 2010
References
1
2
N.D. Heindel and J.R. Reid, J. Heterocycl. Chem., 1980, 17, 1087.
B.S. Holla, B. Kalluraya, K.R. Sridhar, E. Drake, L. M. Thomas, K.K.
Bhandary and M.S. Levine, Eur. J. Med. Chem., 1994, 29, 301.
4p-(4q-Chlorophenyl)-5p-phenyl-2p,4p-dihydrospiro[indole-3,3p-
[1,2,4]triazol]-2(1H)-one (4d): Pale yellow crystals (0.3 g, 66%),
m.p. (ethyl acetate) 220 °C. IR: nmax = 3334 (NH), 3098–3040 (ArCH),
3. V. Mathew, J. Keshavayya and V.P. Vaidya, Eur. J. Med. Chem., 2006, 41,
1048.
4. Triazoles: As promising medicinal agents. The Merck index, Merck Co.
Inc., 13 edn., USA, 1996.
1
1682 (C=O), 1612 (C=N), 1580 (C=C). H NMR: dH = 8.40 (br, s, 1
5
6
J. Haber, Cas. Lek. Cesk., 2001, 140, 596.
A. Brucato, A. Copoola, S. Gianguzza and P.M. Provenzano, Bull. Soc. Ital.
Sper., 1978, 54, 1051.
H, NH, exchangeable with D2O), 7.40–6.80 (m, 13 H, ArH), 6.10 ((br,
s, 1 H, NH, exchangeable with D2O). 13C NMR: dC = 168.8 (C=O),
156.2 (C=N), 132.0, 131.8, 130.2, 130.0 (ArC), 128.5, 128.2 (ArCH),
128.0 (ArCH-p), 126.8, 126.6 (Ar2CH-o), 126.2 (Ar2CH-m), 125.4
(Ar2CH–Cl), 122.0 (ArC), 125.6, 118.6 (ArCH), 89.2 (spiro-C). MS
(70 eV, EI): m/z = 376 [M+2] (38), 374 (100), 330 (22), 271 (16), 214
(30), 160 (32), 91 (80), 114 (28), 113 (32), 77 (24). Anal. Calcd for
C H15N ClO (374.83): C, 67.29; H, 4.04; N, 14.95. Found. C, 67.12;
H2,14.00;4N, 15.00.
7
8
9
D.G. Neilson, R. Roger, J.W.M. Heatlie and L.R. Newlands, Chem. Rev.,
1979, 70, 151.
J.M. Andrews, D.P. Roman, Jr., D.H. Bing and M. Cory, J. Med. Chem.,
1978, 21, 1202.
H.C. Kolb and K.B. Sharpless, Drug Discov. Today, 2003, 8, 1128.
10 M.A.-M. Gomaa and D. Döpp, Synthesis, 2003, 1545.
11 A.A. Aly, N.K. Mohamed, A.A. Hassan and A.-F.E. Mourad, Tetrahedron,
1999, 55, 1111.
12 A.A. Aly and M.A.-M. Gomaa, Can. J. Chem., 2005, 83, 57.
13 A.A. Aly, A.B. Brown, T.I. El-Emary, A.M. Mohamed Ewas and M.
Ramadan. Arkivoc, 2009, i, 150.
14 A.A. Aly, M.A.-M. Gomaa, A.M. Nour-El-Din and M.S. Fahmi, Z.
Naturforsch., 2006, 61B, 1239.
15 Allinger, N.L. MM2 (91) force field Program, obtained from Quantum
Chemistry Program, Indiana University; Molecular Mechanics PM3
Program (ACD/3D), Advanced Chemical Development Inc., Toronto,
Canada, 1988.
4p-(3q-Methylphenyl)-5p-phenyl-2p,4p-dihydrospiro[indole-3,3p-
[1,2,4]triazol]-2(1H)-one (4e): Colourless crystals (0.26 g, 72%),
m.p. (ethanol) 200 °C. IR: nmax = 3334 (NH), 3092–3020 (ArCH),
1
2960–2860 (aliph.-CH), 1684 (C=O), 1612 (C=N), 1586 (C=C). H
NMR: dH = 8.10 (br, s, 1 H, NH, exchangeable with D2O), 8.00 (t, 2 H,
J = 7.4), 7.90 (d, 2 H, J = 7.6), 7.70–6.96 (m, 9 H, ArH), 6.20 (br, s,
1 H, NH, exchangeable with D2O), 2.30 (s, 3 H, CH3). 13C NMR:
dC = 169.0 (C=O), 156.5 (C=N), 142.0, 134.0, 132.2, 131.6, 131.4
(ArC), 129.0, 128.8 (ArCH), 128.6 (ArCH-p), 128.2, 127.6 (Ar2CH-
o), 127.4, 127.2 (Ar2CH-m), 126.3, 119.2 (ArCH), 89.2 (spiro-C),
22.4 (CH3-Ar). MS (70 eV, EI): m/z (%) = 354 (56), 326 (20), 263
(14), 251 (24), 160 (24), 113 (22), 110 (100), 91 (46), 91 (30), 77 (28).
16 F.F. Abdel-Latif, E.Kh. Ahmed, R. Mekheimer and M.M. Mashaly, Arch.
Pharm. Res., 1997, 20, 507.
17 D.L. Coffen and R.I. Fryer, U.S. Patent 3,849, 434, 1974; Chem. Abstr.,
1973, 82, 430044v.